Effective treatment of how to prevent heart disease: A Synthesis of Findings from 34 Studies

  1. Home
  2. Effective treatment of how to prevent heart disease
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effective treatment of how to prevent heart disease: A Synthesis of Findings from 34 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effective treatment of how to prevent heart disease: A Synthesis of Findings from 34 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

The provided research papers focus on the treatment of Hodgkin Lymphoma, a type of cancer affecting the lymphatic system. These studies explore various treatment approaches, including chemotherapy, radiotherapy, and novel targeted therapies.

One key finding is that combined modality treatment, consisting of chemotherapy followed by localized radiotherapy, is the standard of care for patients with early-stage Hodgkin Lymphoma. 19 . However, the long-term adverse effects of radiotherapy, such as secondary malignancies, have led to questioning its role in treatment, with some clinical study groups advocating for chemotherapy alone in certain cases. 19 .

In patients with relapsed or refractory Hodgkin Lymphoma, a more aggressive approach is often required. High-dose chemotherapy followed by autologous stem cell transplantation (AUTO-SCT) is the standard of care in this setting. 15 . However, approximately 50% of patients relapse after AUTO-SCT, and their prognosis is often poor. 15 . Brentuximab Vedotin (BV) has shown efficacy in this setting, and allogeneic (ALLO)-SCT is another option with potential for a cure. 15 .

The use of interim FDG-PET scanning is being explored as a potential tool to predict individual outcomes and guide treatment for Hodgkin Lymphoma. 8 . Early studies suggest that interim PET scans can serve as independent markers of outcome, and ongoing trials are evaluating the use of PET-adapted therapy. 8 .

Treatment Summary

The treatment for Hodgkin Lymphoma depends on the stage of the disease and other factors. For early-stage Hodgkin Lymphoma, the standard approach is a combination of chemotherapy and localized radiotherapy. 19 . However, there is ongoing discussion about the optimal role of radiotherapy due to its long-term adverse effects. 19 . For patients with relapsed or refractory Hodgkin Lymphoma, high-dose chemotherapy followed by AUTO-SCT is the standard of care. 15 . Targeted therapies, such as brentuximab vedotin, and allo-SCT are also options in this setting. 15 .

Benefits and Risks

Benefits Summary

Advances in the treatment of Hodgkin Lymphoma have resulted in significant improvements in cure rates. 8 . The combination of chemotherapy and radiotherapy has proven to be highly effective. 19 . Additionally, the development of new treatment options, such as targeted therapies and immunotherapy, has brought hope for patients with relapsed or refractory disease. 15 , 27 .

Risks Summary

Treatment for Hodgkin Lymphoma can have side effects, including those associated with chemotherapy and radiotherapy. 19 . Radiotherapy, in particular, carries a risk of long-term adverse effects, such as secondary malignancies. 19 . It is crucial to carefully consider the benefits and risks associated with each treatment option before making a decision.

Comparison of Studies

Commonalities Among Studies

Most of the research papers examined highlight the efficacy of combined modality treatment (chemotherapy and radiotherapy) for Hodgkin Lymphoma. 19 , 30 . Furthermore, the studies consistently recognize the importance of targeted therapies and immunotherapy in the treatment of relapsed or refractory disease. 15 , 27 .

Differences Among Studies

There is some variation in the opinions expressed regarding the optimal role of radiotherapy. Some studies advocate for its continued use, while others emphasize the importance of minimizing exposure due to the potential for long-term side effects. 19 . The use of interim PET scanning is another area where research findings vary, with ongoing trials evaluating its potential benefits and limitations. 26 . These differences may reflect variations in research design, target populations, and specific treatment protocols.

Consistency and Contradictions in Findings

While the studies generally agree on the effectiveness of combined modality treatment for Hodgkin Lymphoma, 19 , 30 , there is ongoing debate concerning the long-term consequences of radiotherapy and its appropriate use in various scenarios. 19 . The role of interim PET scanning in treatment decision-making is also a subject of ongoing investigation. 26 . These areas require further research and clinical experience to develop a more comprehensive understanding.

Practical Applications and Considerations

The choice of treatment for Hodgkin Lymphoma is highly personalized and depends on factors such as the stage of the disease, individual health status, and potential side effects. 19 . It is essential to engage in open communication with healthcare providers to make informed decisions about treatment options. It is also vital to be aware of the potential risks and benefits associated with each treatment approach and to actively participate in the management of any side effects that may occur.

Limitations of Current Research

Further research is needed to address several key areas in the treatment of Hodgkin Lymphoma. 19 . These areas include:

  • Exploring ways to reduce the long-term side effects of radiotherapy.
  • Developing more targeted and effective therapies for relapsed or refractory disease.
  • Optimizing the use of interim PET scanning to improve treatment decision-making.
  • Understanding the long-term impact of various treatment approaches on overall survival and quality of life.

Future Research Directions

Future research efforts should focus on refining existing treatment strategies, developing new treatment options, and improving the long-term outcomes for patients with Hodgkin Lymphoma. 19 , 15 , 27 . Specifically, research should aim to:

  • Develop personalized treatment plans tailored to individual patient characteristics.
  • Investigate the use of immunotherapy and targeted therapies to improve treatment outcomes.
  • Explore innovative strategies for preventing and managing treatment-related side effects.
  • Evaluate the long-term impact of treatment on patient well-being and quality of life.

Conclusion

Hodgkin Lymphoma is a complex disease, but significant advances in treatment have led to improved survival rates for many patients. 8 . However, ongoing research is crucial to further enhance treatment efficacy, minimize side effects, and ultimately improve long-term outcomes. 19 . Individuals diagnosed with Hodgkin Lymphoma should work closely with their healthcare providers to develop a personalized treatment plan that addresses their individual needs and goals.

Treatment List

Chemotherapy, radiotherapy, targeted therapy, immunotherapy, AUTO-SCT, allo-SCT, interim PET scanning

Literature analysis of 34 papers
Positive Content
32
Neutral Content
1
Negative Content
1
Article Type
16
13
18
16
34
1.

EORTC trial non-Hodgkin lymphomas.

Author: SomersR, BurgersJ M, QasimM, Van GlabbekeM, DuezN, HayatM

Improved disease-free survival
Improved survival

A study of 468 patients with non-Hodgkin lymphoma found that treatment effectiveness varied based on stage and histological subtype. Maintenance chemotherapy after regional radiotherapy did not significantly improve survival for stage I patients but did improve disease-free survival. Chemotherapy regimens for stage III and IV patients did not differ in effectiveness, and patients with follicular lymphoma had better long-term outcomes.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial.

Author: ArdeshnaK M, SmithP, NortonA, HancockB W, HoskinP J, MacLennanK A, MarcusR E, JelliffeA, VaughanG, Hudson, LinchD C,

No cure for advanced stage low-grade non-Hodgkin lymphomas

Chemotherapy, even when combined with radiation, is not a cure for advanced, slow-growing non-Hodgkin lymphoma. This study compared immediate treatment with chlorambucil to a strategy of delaying chlorambucil until symptoms worsen in patients with advanced, non-symptomatic, slow-growing non-Hodgkin lymphoma.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

3.

Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.

Author: ArakelyanNina, BerthouChristian, DesablensBernard, de GuibertSophie, DelwailVincent, MolesMarie-Pierre, QuittetPhilippe, JaisJean-Philippe, ColonnaPierre, AndrieuJean-Marie,

This study compared two intensive chemotherapy regimens in patients with high-risk Hodgkin lymphoma. The standard ABVD regimen has a 60-70% 5-year freedom from treatment failure rate, but this study aimed to improve outcomes with more intensive regimens.

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.

Author: ArakelyanNina, JaisJean-Philippe, DelwailVincent, BrièreJosette, Moles-MoreauMarie-Pierre, SénécalDelphine, BerthouChristian, DesablensBernard, ColonnaPierre, AndrieuJean-Marie,

Hodgkin lymphoma treatment

This study investigated the impact of a slightly reduced radiation dose on treatment outcomes for patients with early-stage Hodgkin lymphoma (HL). The study compared the effectiveness of a standard treatment regimen, including 3 cycles of ABVD chemotherapy and a tailored radiation schedule, to a regimen with a slightly reduced radiation dose.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

5.

Rituximab in Hodgkin lymphoma: is the target always a hit?

Author: SainiKamal S, AzimHatem A, CocorocchioEmilia, VanazziAnna, SainiMonika Lamba, RavielePaola Rafaniello, PruneriGiancarlo, PeccatoriFedro A

HL treatment

This study reviews the use of rituximab, an anti-CD20 monoclonal antibody, in treating Hodgkin lymphoma (HL). The study explores the rationale for using rituximab in HL subtypes with CD20 expression and provides an overview of its use in clinical practice.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

6.

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma.

Author: HerbstChristine, RehanFareed Ahmed, SkoetzNicole, BohliusJulia, BrillantCorinne, SchulzHolger, MonsefIna, SpechtLena, EngertAndreas

Hodgkin lymphoma treatment
Secondary malignancies

While combined chemotherapy and radiation therapy (CMT) is the standard treatment for early-stage Hodgkin lymphoma (HL), the role of radiation is being questioned due to long-term side effects like secondary cancers. Some studies suggest that chemotherapy alone may be sufficient for this stage of the disease.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

7.

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.

Author: BauerKathrin, SkoetzNicole, MonsefIna, EngertAndreas, BrillantCorinne

Improved HL treatment

This study discusses the two primary international treatment standards for Hodgkin lymphoma (HL): escalated BEACOPP regimen and ABVD regimen.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

8.

Treatment of newly diagnosed advanced stage Hodgkin lymphoma.

Author: UhmJieun, KuruvillaJohn

Improved HL treatment

This review discusses the current standard of care for advanced stage Hodgkin Lymphoma (HL) and explores emerging therapies, including interim FDG-PET scanning and targeted agents like brentuximab vedotin and panabinostat.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

9.

Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-analysis.

Author: dos SantosLucas Vieira, LimaJoão Paulo da Silveira Nogueira, LimaCarmen Sílvia Passos, SasseEmma Chen, SasseAndré Deeke

Improved ALNHL treatment

This systematic review examines the role of radiotherapy (RT) as a consolidative treatment for patients with localized, aggressive non-Hodgkin lymphoma (ALNHL) after chemotherapy. The review aims to provide a reliable assessment for clinical decision-making.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

10.

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.

Author: TebbiCameron K, MendenhallNancy P, LondonWendy B, WilliamsJonathan L, HutchisonRobert E, FitzgeraldThomas J, de AlarcónPedro A, SchwartzCindy, ChauvenetAllen

Improved survival
Reduced therapy

A reduced treatment regimen for low-risk Hodgkin lymphoma based on early response to chemotherapy is safe and effective without compromising survival outcomes.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Language : English

11.

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.

Author: RanceaMichaela, MonsefIna, von TresckowBastian, EngertAndreas, SkoetzNicole

HL treatment

Hodgkin lymphoma (HL) is a common cancer in young adults and is curable for most people, even in advanced stages. However, about 15-20% don't respond to initial treatment and experience a relapse. For these patients, a common treatment is high-dose chemotherapy followed by a stem cell transplant.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

12.

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: a systematic review with meta-analysis.

Author: RanceaMichaela, von TresckowBastian, MonsefIna, EngertAndreas, SkoetzNicole

Hodgkin lymphoma treatment

While most people with Hodgkin lymphoma are successfully treated, about 15% experience a relapse. This study reviewed research on using high-dose chemotherapy (HDCT) followed by a stem cell transplant (ASCT) for patients with relapsing Hodgkin lymphoma. The review found that this approach may delay the return of cancer, but it did not show a clear improvement in overall survival compared to standard chemotherapy. The study also found a slight increase in infections and deaths related to treatment when HDCT was given before HDCT and ASCT.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

13.

Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.

Author: SickingerMarie-Therese, von TresckowBastian, KobeCarsten, EngertAndreas, BorchmannPeter, SkoetzNicole

PET scanning
Hodgkin lymphoma

Hodgkin lymphoma (HL), a type of cancer affecting the lymph nodes, is common in young adults and has a high cure rate (90%). Current treatment involves chemotherapy and radiation, with the intensity of treatment depending on the stage of the disease. This study explores the use of a specific imaging technique (PET scan) to assess how well patients are responding to treatment early on. The study aims to determine if tailoring treatment based on early PET scan results (increasing or decreasing treatment intensity) can improve long-term survival and reduce side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

14.

Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.

Author: KrizJan, ReinartzGabriele, DietleinMarkus, KobeCarsten, KuhnertGeorg, HaverkampHeinz, HaverkampUwe, Engenhart-CabillicRita, HerfarthKlaus, LukasPeter, SchmidbergerHeinz, StaarSusanne, HegerfeldKira, BauesChristian, EngertAndreas, EichHans Theodor

HL treatment

This study aims to determine if relapses in advanced Hodgkin lymphoma (HL) occur in the areas treated with radiation. It also investigates whether the radiation field definitions used by the German Hodgkin Study Group (GHSG) are sufficient, as there is no standardized approach for treating advanced HL across different research groups.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

15.

Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents.

Author: MartinoMassimo, FestucciaMoreno, FedeleRoberta, ConsoleGiuseppe, CimminielloMichele, GavarottiPaolo, BrunoBenedetto

Hodgkin lymphoma treatment

Standard treatment for Hodgkin lymphoma (HL) that returns after treatment or doesn't respond to initial treatment (relapsed/refractory, R/R) includes chemotherapy followed by a stem cell transplant from the patient's own body (AUTO-SCT). However, about half of patients relapse after this, and their outlook is poor. Brentuximab Vedotin (BV) has shown promise in treating these patients, and a transplant from a donor (ALLO-SCT) may offer a cure for some.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

16.

PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis.

Author: SickingerMarie T, von TresckowBastian, KobeCarsten, BorchmannPeter, EngertAndreas, SkoetzNicole

HL treatment

Hodgkin lymphoma (HL) is a common cancer in young adults and is highly curable. Treatment for HL is being adjusted based on a scan called a PET scan, which is done during treatment. A negative PET scan indicates good response, while a positive scan means the treatment isn't working as well. This is leading to research on giving less or more aggressive treatment based on the PET scan results.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

17.

[Role of radiotherapy in the management of non-Hodgkin lymphomas].

Author: GastaudL, RossignolB, PeyradeF, RéD, ThariatJ, ThyssA, DoyenJ

Good option for lymphoma

This review summarizes recent research on radiotherapy for non-Hodgkin lymphoma. While radiotherapy is effective in certain types and stages of non-Hodgkin lymphoma, its role in high-grade lymphomas is still being investigated through ongoing trials.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : French

18.

Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.

Author: SasseStephanie, BröckelmannPaul J, GoergenHelen, PlütschowAnnette, MüllerHorst, KreisslStefanie, BuerkleCarolin, BorchmannSven, FuchsMichael, BorchmannPeter, DiehlVolker, EngertAndreas

HL treatment

This study looked at the long-term outcomes of different treatments for early-stage Hodgkin lymphoma (HL). The results support current treatment approaches that use a combination of chemotherapy and radiation, with lower doses of radiation and chemotherapy than in the past. Overall, these treatments were effective and safe in the long term, but continued follow-up is needed to monitor for potential long-term side effects.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

19.

Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.

Author: BlankOliver, von TresckowBastian, MonsefIna, SpechtLena, EngertAndreas, SkoetzNicole

Hodgkin lymphoma treatment

The standard treatment for early-stage Hodgkin lymphoma (HL) is a combination of chemotherapy and radiation. However, the use of radiation is being questioned due to potential long-term side effects, such as new cancers. Some groups are now advocating for using only chemotherapy for this type of cancer.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

20.

Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.

Author: SkoetzNicole, WillAndrea, MonsefIna, BrillantCorinne, EngertAndreas, von TresckowBastian

This study compares two different international standards for treating Hodgkin lymphoma (HL): chemotherapy with escalated BEACOPP and chemotherapy with ABVD.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

21.

ABVD or BEACOPP<sub>baseline</sub> along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'&#201;tude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

Author: FerméChristophe, ThomasJosé, BricePauline, CasasnovasOlivier, VranovskyAndrej, BolognaSerge, LugtenburgPieternella J, BouabdallahRéda, CardePatrice, SebbanCatherine, EghbaliHouchingue, SallesGilles, van ImhoffGustaaf W, ThyssAntoine, NoordijkEvert M, RemanOumédaly, LybeertMarnix L M, JanvierMaud, SpinaMichele, AudhuyBruno, RaemaekersJohn M M, DelarueRichard, AnglaretBruno, de WeerdtOkke, MarjanovicZora, TersteegRobbert J H A, de JongDaphne, BrièreJosette, Henry-AmarMichel,

4-ABVD for early HL

Four cycles of ABVD followed by involved-field radiotherapy yielded high disease control in patients with early-stage Hodgkin lymphoma (HL) and risk factors.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

22.

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Author: FranklinJeremy, EichenauerDennis A, BeckerIngrid, MonsefIna, EngertAndreas

Reduced secondary malignancies

This meta-analysis examined the risk of secondary malignancies following various treatment approaches for newly diagnosed Hodgkin lymphoma, including chemotherapy and radiotherapy, highlighting the need for careful consideration of long-term risks.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

23.

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.

Author: EichenauerDennis A, BeckerIngrid, MonsefIna, ChadwickNicholas, de SanctisVitaliana, FedericoMassimo, FortpiedCatherine, GianniAlessandro M, Henry-AmarMichel, HoskinPeter, JohnsonPeter, LuminariStefano, BelleiMonica, PulsoniAlessandro, SydesMatthew R, ValagussaPinuccia, VivianiSimonetta, EngertAndreas, FranklinJeremy

Improved overall survival
Improved progression-free survival
Increased risk of acute myeloid leukemia

This meta-analysis investigated the influence of treatment intensification and reduced intensity approaches in Hodgkin lymphoma on secondary malignancies, progression-free survival, and overall survival. Dose-intensified chemotherapy improved progression-free survival but increased the risk of leukemia/myelodysplastic syndromes.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

24.

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.

Author: ThomasJosé, FerméChristophe, NoordijkEvert M, MorschhauserFranck, GirinskyThéodore, GaillardIsabelle, LugtenburgPieternella J, AndréMarc, LybeertMarnix L M, StamatoullasAspasia, BeijertMax, HéliasPhilippe, EghbaliHouchingue, GabarreJean, van der MaazenRichard W M, JaubertJérôme, BouabdallahKrimo, BoulatOlivier, RoesinkJudith M, ChristianBernard, OngFrancisca, BordessouleDominique, TertianGérard, GonzalezHugo, VranovskyAndrej, QuittetPhilippe, TirelliUmberto, de JongDaphne, AudouinJosée, AlemanBerthe M P, Henry-AmarMichel

HL treatment

Patients with early-stage Hodgkin lymphoma (HL) generally do well with a combination of chemotherapy and radiation therapy, but the best approach for radiation dose and the use of chemotherapy alone is still being debated. This study investigates whether reducing the radiation dose or omitting radiation altogether after chemotherapy is safe and effective.

Equivalence TrialA clinical trial designed to show that a new treatment is equivalent in efficacy/safety to an existing treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

25.

Hodgkin Lymphoma in Adults.

Author: BröckelmannPaul J, EichenauerDennis A, JakobTina, FollmannMarkus, EngertAndreas, SkoetzNicole

Improved survival
Late sequelae

The use of positron emission tomography (PET) is recommended in the initial diagnostic evaluation and for the guidance of treatment in advanced stages of Hodgkin lymphoma. The five-year survival of patients with Hodgkin lymphoma is 95%.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

26.

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.

Author: FuchsMichael, GoergenHelen, KobeCarsten, KuhnertGeorg, LohriAndreas, GreilRichard, SasseStephanie, ToppMax S, SchäferErhardt, HertensteinBernd, SoeklerMartin, VogelhuberMartin, ZijlstraJosée M, KellerUlrich Bernd, KrauseStefan W, WilhelmMartin, MaschmeyerGeorg, ThiemerJulia, DührsenUlrich, MeissnerJulia, ViardotAndreas, EichHans, BauesChristian, DiehlVolker, RosenwaldAndreas, von TresckowBastian, DietleinMarkus, BorchmannPeter, EngertAndreas

Improved HL treatment

This study investigates the role of positron emission tomography (PET) after 2 cycles of ABVD chemotherapy (PET-2) in guiding treatment for patients with early-stage favorable Hodgkin lymphoma (HL).

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

27.

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.

Author: BröckelmannPaul J, GoergenHelen, KellerUlrich, MeissnerJulia, OrdemannRainer, HalbsguthTeresa V, SasseStephanie, SöklerMartin, KerkhoffAndrea, MathasStephan, HüttmannAndreas, BormannMatthias, ZimmermannAndreas, MettlerJasmin, FuchsMichael, von TresckowBastian, BauesChristian, RosenwaldAndreas, KlapperWolfram, KobeCarsten, BorchmannPeter, EngertAndreas

Improved cHL treatment

This study (NIVAHL trial) evaluates nivolumab as a first-line treatment for early-stage unfavorable classic Hodgkin lymphoma (cHL), aiming to develop a highly effective and tolerable systemic therapy.

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

28.

Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review.

Author: DalalMehul, GuptaJatin, PriceKim, ZomasAthanasios, MiaoHarry, AshayeAjibade

Improved HL treatment

This study assesses the safety and efficacy of ABVD, BEACOPP, and A+AVD for treating advanced-stage Hodgkin lymphoma (HL).

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

29.

Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.

Author: EichenauerDennis A, MüllerHorst, ElgerLeonard, GoergenHelen, FuchsMichael, KreisslStefanie, BöllBoris, DiehlVolker, von TresckowBastian, BorchmannPeter, EngertAndreas

cHL treatment

Non-Hodgkin lymphoma (NHL) after Hodgkin lymphoma (cHL) is rare, happening in about 1.5% of patients. It usually occurs in older people, with the median age at diagnosis being 54 years old. The average time until developing NHL after cHL is 44 months, and the five-year survival rate is only about 44%. This suggests that NHL after cHL is often fatal.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

30.

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Author: BorchmannPeter, PlütschowAnnette, KobeCarsten, GreilRichard, MeissnerJulia, ToppMax S, OstermannHelmut, DierlammJudith, MohmJohannes, ThiemerJulia, SöklerMartin, KerkhoffAndrea, AhlbornMiriam, HalbsguthTeresa V, MartinSonja, KellerUlrich, BalabanovStefan, PabstThomas, VogelhuberMartin, HüttmannAndreas, WilhelmMartin, ZijlstraJosée M, MocciaAlden, KuhnertGeorg, BröckelmannPaul J, von TresckowBastian, FuchsMichael, KlimmBeate, RosenwaldAndreas, EichHans, BauesChristian, MarnitzSimone, HallekMichael, DiehlVolker, DietleinMarkus, EngertAndreas

Hodgkin lymphoma treatment

This study investigated whether radiation therapy could be omitted for patients with early-stage Hodgkin lymphoma who respond well to chemotherapy. The study aimed to determine if a specific combination of chemotherapy regimens could be effective enough to avoid radiation therapy, which can have long-term side effects, especially for young adults.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

31.

Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).

Author: GillessenSarah, PlütschowAnnette, FuchsMichael, MarkovaJana, GreilRichard, ToppMax S, MeissnerJulia, ZijlstraJosée M, EichenauerDennis A, BröckelmannPaul J, DiehlVolker, BorchmannPeter, EngertAndreas, von TresckowBastian

Intensified chemotherapy for Hodgkin Lymphoma

This study followed up on a previous trial that compared two different chemotherapy regimens for early-stage Hodgkin lymphoma. While the more intensive regimen (escalated BEACOPP followed by ABVD) showed a benefit in preventing disease recurrence in the short term, there was no difference in overall survival between the two groups. This follow-up analysis aimed to evaluate the long-term effectiveness and side effects of this treatment approach.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

33.

Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis.

Author: ShardaEsha, PatelRaahil S, Juárez-SalcedoLuis Miguel, DaliaSamir, HannaCatherine H, GruhonjicHanan, PonnagantiBharat S, MhaskarRahul

RIT for NHL
Association with second neoplasms

This meta-analysis evaluated the association between radioimmunotherapy (RIT) and the development of second neoplasms, specifically acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), in patients with non-Hodgkin's lymphoma (NHL). While RIT shows promise in treating NHL, this study aimed to determine the safety of the therapy by assessing the incidence of these secondary cancers.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

34.

Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

Author: Mauz-KörholzChristine, Landman-ParkerJudith, BalwierzWalentyna, AmmannRoland A, AndersonRichard A, AttarbaschiAndische, BarteltJörg M, BeishuizenAuke, BoudjemaaSabah, CepelovaMichaela, ClaviezAlexander, DawStephen, DieckmannKarin, Fernández-TeijeiroAna, FossåAlexander, GattenlöhnerStefan, GeorgiThomas, HjalgrimLisa L, HraskovaAndrea, KarlénJonas, KlugeRegine, KurchLars, LeblancThiery, MannGeorg, MontraversFrancoise, PearsJean, PelzTanja, RajićVladan, RamsayAlan D, StoevesandtDietrich, UyttebroeckAnne, VordermarkDirk, KörholzDieter, HasencleverDirk, WallaceWilliam Hamish

Treatment for classical Hodgkin lymphoma

This study investigated the potential for omitting radiotherapy in patients with classical Hodgkin lymphoma who achieve a good response to chemotherapy, as well as the impact of modified consolidation chemotherapy on gonadotoxicity.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.